PAVmed
PAVM
PAVM
61 hedge funds and large institutions have $3.76M invested in PAVmed in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $4.62M → $3.76M (-$869K)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
61
Holding in Top 10
–
Calls
$62K
Puts
$5K
Top Buyers
| 1 | +$161K | |
| 2 | +$103K | |
| 3 | +$11K | |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$7.58K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.45K |
Top Sellers
| 1 | -$45.6K | |
| 2 | -$39.3K | |
| 3 | -$32.6K | |
| 4 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$16.7K |
| 5 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
-$15.6K |